# Syngene International

Integrated safety assessment — BMS collaboration extended to 2035; PDE/HBEL toxicology; research CRDMO.

Source: https://en.bioecon.ru/companies/syngene/
Updated: 2026-07-22

- Country: India

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $195M (Historical) | https://intuitionlabs.ai/companies/cro/syngene-international |
| Capacity | 50,000L total single-use bioreactor capacity for large molecule services | https://www.biocon.com/docs/Syngene-Annual-Report-2024-25.pdf, https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.syngeneintl.com/wp-content/uploads/2026/04/Fact-Sheet-Q4-FY26.pdf |
| Certification | ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 13485:2016, ISO/IEC 27001:2022, ISO 15189:2012, GLP, NABL, CAP, AAALAC, and 5S certification | https://www.biocon.com/docs/Syngene-Annual-Report-2024-25.pdf, https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.bseindia.com/xml-data/corpfiling/Attachhis/53091019-7daa-44d0-bc7d-fd03b4c2899e.pdf |
| Regulatory approval | US FDA, EMA, UK VMD, Health Canada, PMDA, MHRA, AGES, ANVISA, and CDSCO approved/inspected facilities | https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.bseindia.com/xml-data/corpfiling/Attachhis/53091019-7daa-44d0-bc7d-fd03b4c2899e.pdf, https://www.syngeneintl.com/about-us/ |
| Production site | Bengaluru (India), Mangaluru (India), Hyderabad (India), and Baltimore (USA) | https://www.biocon.com/docs/Syngene-Annual-Report-2024-25.pdf, https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.bseindia.com/xml-data/corpfiling/Attachhis/53091019-7daa-44d0-bc7d-fd03b4c2899e.pdf |
| Headcount | 8,235 employees (including over 5,600 scientists) | https://www.biocon.com/docs/Syngene-Annual-Report-2024-25.pdf, https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.bseindia.com/xml-data/corpfiling/Attachhis/53091019-7daa-44d0-bc7d-fd03b4c2899e.pdf |
| Revenue | Rs. 37,387 million (FY26) | https://www.bseindia.com/xml-data/corpfiling/AttachHis/47df660d-9183-4cf3-b1a3-a77644a0c641.pdf, https://www.syngeneintl.com/wp-content/uploads/2026/04/Fact-Sheet-Q4-FY26.pdf |

Independent sources: biocon.com, bseindia.com, intuitionlabs.ai

## Technologies

- [Toxics screening (toxicomics, service)](https://en.bioecon.ru/technology/toxics-screening-toxicomics-service/)